Additionally, our data confirm previous findings on the prognostic abilities of circulating levels of VEGF [40, 41] and CXCL8 [42] in CRC patients demonstrating that this type of methodology is highly reproducible. This evidence concerns the gene VEGFA and colorectal carcinoma.